Malaysian pharma firm to manufacture Sinovac vaccine by March

January 13, 2021

Malaysia’s largest integrated pharmaceutical company, Phamaniaga Bhd is manufacturing two million doses/month of  Sinovac Covid-19 vaccine starting this March. The deal between the two companies is for the supply of 14 million doses of the vaccine  to be carried out for fill and finish activity.

According to Pharmaniaga’s Managing Director Datuk Zulkarnain Md Eusope, the vaccine would be the first to be manufactured in Malaysia at the Puchong-sited plant owned by Pharmaniaga’s wholly-owned subsidiary, Pharmaniaga LifeSciences Sdn Bhd. The company is also investing RM3 million to retrofit the plant for the production of the vaccine.

Pharmaniaga has been engaging with the National Pharmaceutical Regulatory Agency (NPRA) to ensure that its plant continues to be in high compliance with regulatory requirements. 

Category: Features, Pharmaceuticals

Comments are closed.